Lopinavir, an antiretroviral drug against human immunodeficiency virus (HIV), was administered through various routes to an HIV-infected patient with duodenal malignant lymphoma. Antiretroviral drugs were first administered through a jejunal tube, and then through bypass route between the stomach and jejunum that was 20 cm distal from the ligament of Treitz after surgery. Oral administration through the bypass achieved sufficient serum concentrations of lopinavir, whereas administration through the jejunal tube did not.
Introduction

Patients infected with the human immunodeficiency virus (HIV) can now survive longer thanks to recent advances in antiretroviral therapy (ART). Although the present case is a patient with acquired immunodeficiency diseases syndrome (AIDS)-related malignant lymphoma of the duodenum, non-AIDS-related carcinoma has been increasing among HIVinfected patients in the ART era (1). For a variety of reasons, such as metastasis in the brain and upper gastrointestinal tract, the need for enteral feeding has been increasing. The site of absorption of ART within the alimentary tract remains poorly defined in humans (2).
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